AIM IMMUNOTECH INC. Proceeds from Common Stock Issued
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Common Stock Issued of $2.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-07
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for the quarter ending 2026-06-30 was $537.00K, a 411.43% increase year-over-year.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for the quarter ending 2026-03-31 was $2.00M, a 203.18% increase year-over-year.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $105.00K.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $660.00K.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for fiscal 2021 was $13.04M, a 78.71% decline from fiscal 2020.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for fiscal 2020 was $61.25M, a 300.24% increase from fiscal 2019.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for fiscal 2019 was $15.30M, a 201.83% increase from fiscal 2018.
- AIM IMMUNOTECH INC. proceeds from issuance of common stock for fiscal 2018 was $5.07M, a 109.76% increase from fiscal 2017.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.54M 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | $2.00M 10-Q · filed 2026-05-15 | |||||
| 2025-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $765.00K 10-Q · filed 2026-08-07 | ||||
| 2025-03-31 | $660.00K 10-Q · filed 2026-05-15 | |||||
| 2022-06-30 | $55.00K 10-Q · filed 2022-08-15 | |||||
| 2021-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $155.00K derived: sum of 2 quarters · filed 2022-03-31 | $155.00K derived: sum of 3 quarters · filed 2022-08-15 | $13.04M 10-K · filed 2022-03-31 | ||
| 2021-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $30.00K derived: sum of 2 quarters · filed 2022-08-15 | $12.92M 10-Q · filed 2021-11-15 | $16.10M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $12.89M 10-Q · filed 2022-08-15 | $16.07M derived: sum of 3 quarters · filed 2022-08-15 | $33.31M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $12.89M 10-Q · filed 2022-05-13 | $16.07M derived: sum of 2 quarters · filed 2022-05-13 | $33.31M derived: sum of 3 quarters · filed 2022-05-13 | $48.36M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $20.43M derived: sum of 2 quarters · filed 2022-03-31 | $35.48M derived: sum of 3 quarters · filed 2022-03-31 | $61.25M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $17.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $32.29M derived: sum of 2 quarters · filed 2021-11-15 | $58.07M 10-Q · filed 2021-11-15 | $58.06M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $15.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $40.82M 10-Q · filed 2021-08-16 | $40.82M derived: sum of 3 quarters · filed 2021-08-16 | $50.44M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $25.77M 10-Q · filed 2021-05-17 | $25.77M derived: sum of 2 quarters · filed 2021-05-17 | $35.39M derived: sum of 3 quarters · filed 2021-05-17 | $36.34M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $9.61M derived: sum of 2 quarters · filed 2021-03-31 | $10.57M derived: sum of 3 quarters · filed 2021-03-31 | $15.30M 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $9.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $10.57M derived: sum of 2 quarters · filed 2020-11-12 | $15.31M 10-Q · filed 2020-11-12 | $15.47M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $955.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $5.69M 10-Q · filed 2020-08-14 | $5.86M derived: sum of 3 quarters · filed 2020-08-14 | $6.00M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $4.73M 10-Q · filed 2020-05-14 | $4.90M derived: sum of 2 quarters · filed 2020-05-14 | $5.04M derived: sum of 3 quarters · filed 2020-05-14 | $7.48M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $306.00K derived: sum of 2 quarters · filed 2020-03-30 | $2.74M derived: sum of 3 quarters · filed 2020-03-30 | $5.07M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $2.58M derived: sum of 2 quarters · filed 2019-11-14 | $4.90M 10-Q · filed 2019-11-14 | $5.14M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $4.76M 10-Q · filed 2019-08-14 | $5.00M derived: sum of 3 quarters · filed 2019-08-14 | $5.07M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $2.33M 10-Q · filed 2019-05-15 | $2.56M derived: sum of 2 quarters · filed 2019-05-15 | $2.63M derived: sum of 3 quarters · filed 2019-05-15 | $3.87M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $302.00K derived: sum of 2 quarters · filed 2019-04-01 | $1.54M derived: sum of 3 quarters · filed 2019-04-01 | $2.42M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.30M derived: sum of 2 quarters · filed 2018-11-14 | $2.18M 10-Q · filed 2018-11-14 | $2.23M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-07-31 | $65.00K 10-Q · filed 2018-05-15 | |||||
| 2017-07-30 | $65.00K 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $2.12M 10-Q · filed 2018-08-14 | $2.17M derived: sum of 3 quarters · filed 2018-08-14 | $6.70M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $875.00K 10-Q · filed 2018-05-15 | $925.00K derived: sum of 2 quarters · filed 2018-05-15 | $5.46M derived: sum of 3 quarters · filed 2018-05-15 | $5.62M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $4.58M derived: sum of 2 quarters · filed 2018-03-30 | $4.74M derived: sum of 3 quarters · filed 2018-03-30 | $4.74M 10-K · filed 2018-03-30 | ||
| 2016-09-30 | $4.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $4.69M derived: sum of 2 quarters · filed 2017-11-14 | $4.69M 10-Q · filed 2017-11-14 | $4.70M derived: sum of 4 quarters · filed 2018-03-30 | ||
| 2016-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $163.00K 10-Q · filed 2017-08-14 | $164.00K derived: sum of 3 quarters · filed 2018-03-30 | $551.00K derived: sum of 4 quarters · filed 2018-03-30 | ||
| 2016-03-31 | $2.00K 10-Q · filed 2017-05-15 | $3.00K derived: sum of 2 quarters · filed 2018-03-30 | $390.00K derived: sum of 3 quarters · filed 2018-03-30 | $4.44M derived: sum of 4 quarters · filed 2018-03-30 | ||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $388.00K derived: sum of 2 quarters · filed 2018-03-30 | $4.44M derived: sum of 3 quarters · filed 2018-03-30 | $9.68M 10-K · filed 2018-03-30 | ||
| 2015-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $4.44M derived: sum of 2 quarters · filed 2016-11-14 | $9.68M 10-Q · filed 2016-11-14 | $12.73M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $9.29M 10-Q · filed 2016-08-15 | $12.35M derived: sum of 3 quarters · filed 2017-03-31 | $13.65M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-03-31 | $5.24M 10-Q · filed 2016-05-16 | $8.30M derived: sum of 2 quarters · filed 2017-03-31 | $9.60M derived: sum of 3 quarters · filed 2017-03-31 | $11.67M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2014-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $4.36M derived: sum of 2 quarters · filed 2017-03-31 | $6.43M derived: sum of 3 quarters · filed 2017-03-31 | $12.82M 10-K · filed 2017-03-31 | ||
| 2014-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $3.38M derived: sum of 2 quarters · filed 2015-11-16 | $9.76M 10-Q · filed 2015-11-16 | $10.01M derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2014-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $8.46M 10-Q · filed 2015-08-12 | $8.71M derived: sum of 3 quarters · filed 2016-03-29 | $8.71M derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2014-03-31 | $6.38M 10-Q · filed 2015-05-12 | $6.63M derived: sum of 2 quarters · filed 2016-03-29 | $6.63M derived: sum of 3 quarters · filed 2016-03-29 | $6.63M derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2013-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $249.00K derived: sum of 2 quarters · filed 2016-03-29 | $249.00K derived: sum of 3 quarters · filed 2016-03-29 | $249.00K 10-K · filed 2016-03-29 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | $13.73M derived: sum of 4 quarters · filed 2015-03-19 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | $13.73M derived: sum of 3 quarters · filed 2015-03-19 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $13.73M derived: sum of 2 quarters · filed 2015-03-19 | ||||
| 2012-12-31 | $13.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $23.00M 10-K · filed 2015-03-19 | ||||
| 2012-09-30 | $9.27M 10-Q · filed 2013-11-08 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $0.00 derived: sum of 2 quarters · filed 2014-03-14 | $0.00 10-K · filed 2014-03-14 | |||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $0.00 10-Q · filed 2011-11-09 | ||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 | |||||
| 2010-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$1.00K derived: sum of 2 quarters · filed 2013-03-18 | $292.00K 10-K · filed 2013-03-18 | $293.00K 10-K · filed 2012-03-14 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $293.00K 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $293.00K 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $55.57M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |